USPTO 2015–2025 USPTO PatentsView US Corporation

Entellus Medical, Inc.

USPTO PatentsView assignee record - 55 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Entellus ranks #6,139 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 7 technology areas.

#6,139
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.4/100)
18.1
avg claims per patent
+4%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6139 · US Corporation #6,139 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 55 grants
  • UPPER-Q #6,139/49,997
  • PHOTO-FINISH East Carolina…
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 39.4/100
  • CLAIMS-RICH 18.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +4% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: East Carolina University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Entellus’s 39.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Entellus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Entellus's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Entellus?

Each dot is one of Entellus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Entellus’s own 18.1 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Entellus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 54.955.055.05555.055.055.1 0510152025 Granted patents (volume) Avg claims / patent Enzo Life Sciences, Inc. - 55, 21.75Enzo Life SciencesEugene Technology Co., Ltd. - 55, 9.47Eugene TechnologyEast Carolina University - 55, 17.02East Carolina Uni…Ellenberger & Poensgen GmbH - 55, 10.24Ellenberger & Poe…Erasmus University Medical Center Rotterdam - 55, 13.24Erasmus Universit…Exo Imaging, Inc. - 55, 23.44Exo ImagingFloricultura B.V. - 55, 1Floricultura B VFMC Kongsberg Subsea AS - 55, 13.44FMC Kongsberg Sub…Entellus Medical, Inc. - 55, 18.05Entellus Medical
Entellus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Entellus's grants concentrate

Entellus Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 94.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2022. By volume, Entellus sits between Enzo Life Sciences, Inc. and FMC Kongsberg Subsea AS.

Entellus's three-year grant acceleration

Entellus Medical, Inc. shows 15 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Entellus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Entellus holds 55 patents at rank #6,141, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Entellus

By rank, the assignees closest to #6,141 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Entellus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Entellus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Entellus ranks #361 of 7,127 assignees by patent count in that subclass.

Entellus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2015201620172018201920202021202220232024 6
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Entellus Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 7.3%
2016 10 18.2%
2017 4 7.3%
2018 3 5.5%
2019 6 10.9%
2020 4 7.3%
2021 9 16.4%
2022 1 1.8%
2023 8 14.5%
2024 6 10.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Entellus Medical, Inc.'s patent record in context - here's where to go next.

  • Entellus Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.5% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #6,139 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Entellus Medical, Inc. against Enzo Life Sciences, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.